SPL 0.00% 9.9¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-7

  1. 11,198 Posts.
    lightbulb Created with Sketch. 697
    It is disreputable to not give the market at least a line about why the results were not released on time IMO. The AGM is not far off. Insignificant experiments get a whole media release.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.